Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 104.40 | N/A |
| PEG Ratio (TTM) | 0.34 | N/A |
| P/S Ratio (TTM) | 3.05 | N/A |
| P/B Ratio (TTM) | 4.40 | N/A |
| P/FCF Ratio (TTM) | 29.83 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.77% | N/A |
| ROE (TTM) | 4.35% | N/A |
| Net Profit Margin (TTM) | 2.91% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 352.77% | -897.51% | N/A |
| Revenue | 3.57% | 31.63% | N/A |
| Net Income | 252.59% | -942.58% | N/A |
| Cash Flow | 24.26% | 138.50% | N/A |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.90 | N/A |
| Quick Ratio (TTM) | 2.26 | N/A |
| D/E Ratio (TTM) | 0.91 | N/A |
| Interest Coverage (TTM) | 3.34 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 3.16 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |